These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 5496135)

  • 1. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.
    Sugiura A; Yanagawa H; Enomoto C; Ueda M; Tobita K
    J Infect Dis; 1970 Dec; 122(6):472-8. PubMed ID: 5496135
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain.
    Hoskins TW; Davies JR; Allchin A; Miller CL; Pollock TM
    Lancet; 1973 Jul; 2(7821):116-20. PubMed ID: 4124042
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on the immunity against influenza in the population of Milan in the fall of 1972. Distribution of h.i.a. (hemagglutination inhibition antibodies) against A-Hong Kong-68 and A-England-42-72 viruses and the immunizing effectiveness of current vaccines].
    Profeta ML; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(1):25-31. PubMed ID: 4714450
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization.
    Foy HM; Cooney MK; McMahan R; Bor E; Grayston JT
    JAMA; 1971 Aug; 217(8):1067-71. PubMed ID: 5109428
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972.
    Stiver HG; Graves P; Eickhoff TC; Meiklejohn G
    N Engl J Med; 1973 Dec; 289(24):1267-71. PubMed ID: 4127183
    [No Abstract]   [Full Text] [Related]  

  • 7. Hong Kong influenza immunologic recapitulation.
    Marine WM; Workman WM
    Am J Epidemiol; 1969 Nov; 90(5):406-15. PubMed ID: 5356948
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological evidence of A2 Hong Kong influenza in Sudan.
    Salim AR
    Trop Geogr Med; 1974 Jun; 26(2):210-3. PubMed ID: 4854250
    [No Abstract]   [Full Text] [Related]  

  • 9. Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man.
    Masurel N; Marine WM
    Am J Epidemiol; 1973 Jan; 97(1):44-9. PubMed ID: 4684066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influenza in Kabul 1968-69 due to influenza virus A2 Hong Kong-68. A contribution to influenza surveillance in Afghanistan].
    Thraenhart O; Sery V; Habib A; Amin F
    Zentralbl Bakteriol Orig A; 1971 Oct; 218(2):160-7. PubMed ID: 4403536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serological studies during the course of the 1965 influenza A2 epidemic in Magdeburg].
    Offenhauer R; Tůmová B; Skvrnová K
    Z Med Mikrobiol Immunol; 1967; 153(4):284-96. PubMed ID: 5615159
    [No Abstract]   [Full Text] [Related]  

  • 12. Serological evidence of infection with A2 Hong Kong influenza virus during the epidemic in Britain 1968-9.
    Pereira MS; Miller DL; Clarke M
    Br Med J; 1969 Dec; 4(5686):815. PubMed ID: 5359955
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to intradermal vaccination with A2, Hong Kong variant, influenza vaccine.
    McElroy JT; Szwed JJ
    N Engl J Med; 1969 Nov; 281(19):1076. PubMed ID: 5343531
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines.
    Mogabgab WJ; Leiderman E
    JAMA; 1970 Mar; 211(10):1672-6. PubMed ID: 4984268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antigenicity of various influenza vaccines in man].
    Kuwert E; Höhner PG; Bertrams J; Schriever O
    Dtsch Med Wochenschr; 1971 May; 96(22):938-45. PubMed ID: 4325348
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine].
    Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N
    Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic variants of influenza B virus.
    Schild GC; Pereira MS; Chakraverty P; Coleman MT; Dowdle WR; Chang WK
    Br Med J; 1973 Oct; 4(5885):127-31. PubMed ID: 4201694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of the diagnosis, clinical course and prevention of influenza A2 (Hong Kong) 68 in newborn and young infants].
    Ritova VV; Schastnyĭ EI; Oganesian OT; Chebotarev VV; Larionov AS
    Sov Med; 1971; 34(3):93-8. PubMed ID: 5116874
    [No Abstract]   [Full Text] [Related]  

  • 20. Outbreak of Hong Kong influenza in Milwaukee, winter of 1968-69.
    Piraino FF; Brown EM; Krumbiegel ER
    Public Health Rep (1896); 1970 Feb; 85(2):140-50. PubMed ID: 4312890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.